Cigna Q2 2026 profit rises; full-year adjusted EPS outlook raised to at least $30.45
The Cigna Group reported second quarter 2026 results, with total revenues up 7% to $71.7 billion and shareholders' net income of $1.7 billion, or $6.29 per share, versus $5.71 a year earlier. Adjusted income from operations rose 6% to $2.1 billion, or $7.78 per share, and the company raised its full-year 2026 adjusted per-share outlook to at least $30.45, an increase of $0.10. For shareholders, the higher outlook and improved headline profit are offset in part by a sharp drop in Pharmacy Benefit Services profit.
Key points
- Total revenues rose 7% to $71.7 billion; shareholders' net income was $1.7 billion, or $6.29 per share, compared with $1.5 billion, or $5.71 per share, in Q2 2025.
- Adjusted income from operations was $2.1 billion, or $7.78 per share, compared with $7.20 per share in Q2 2025.
- Full-year 2026 adjusted income from operations outlook increased to at least $30.45 per share, up $0.10 from the prior projection.
- Pharmacy Benefit Services adjusted pre-tax income fell 27% year over year, while Cigna Healthcare adjusted pre-tax income rose 17%.
The filing
Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 1:21 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on July 30, 2026.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.